G53D (p.Gly53Asp) variant of FBN2 (Fibrillin-2)

G53D (p.Gly53Asp) in FBN2 (Fibrillin-2) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.63 / 1. The record also includes population frequency data, published literature, and structural context.

G53D (p.Gly53Asp) variant details